<![CDATA[MFN drug pricing]]>I was talking to a pharma exec at the Greenwich country club (I was at a fundraiser there). He was telling me that a lot of big pharma are going to hit their MFN targets (reminder - that’s the thing where you can’t sell the drugs in Europe for less than in the US) by simply not marketing their drugs in Europe and charging the normal price here.

I imagine it’s more politically palatable to offer the drugs to the Europeans at US prices and let them just decline.

]]>https://nodebb.the-new-coffee-room.club/topic/39614/mfn-drug-pricingRSS for NodeThu, 14 May 2026 07:24:22 GMTThu, 14 May 2026 01:43:41 GMT60<![CDATA[Reply to MFN drug pricing on Thu, 14 May 2026 02:01:11 GMT]]>MFN is ‘most favored nation’.

No, when I said not market, I mean they wouldn’t put them up for sale at all. Or as I suggested, write off the idea of selling to Europe, price the US as they normally do, offer them to Europe at that price, be unwilling to budge given MFN, and accept that Europe will turn down the drugs in most cases.

]]>https://nodebb.the-new-coffee-room.club/post/362570https://nodebb.the-new-coffee-room.club/post/362570Thu, 14 May 2026 02:01:11 GMT<![CDATA[Reply to MFN drug pricing on Thu, 14 May 2026 01:49:40 GMT]]>So, they would not market them, but would still sell them in Europe?

(What does MFN mean?)

]]>https://nodebb.the-new-coffee-room.club/post/362567https://nodebb.the-new-coffee-room.club/post/362567Thu, 14 May 2026 01:49:40 GMT